Back to Search Start Over

Factors predictive of lymph node metastasis in the follicular variant of papillary thyroid carcinoma

Authors :
Frederic Sebag
Delphine Drui
Céline Brient
Eric Mirallié
Christelle Volteau
Jf Henry
Muriel Mathonnet
Antoine Hamy
M. Roy
Claire Blanchard
unité de recherche de l'institut du thorax UMR1087 UMR6291 (ITX)
Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Nantes - UFR de Médecine et des Techniques Médicales (UFR MEDECINE)
Université de Nantes (UN)-Université de Nantes (UN)
Plateforme de Biométrie [Nantes]
Centre hospitalier universitaire de Nantes (CHU Nantes)
Service de chirurgie générale et endocrinienne
Hôpital de la Timone [CHU - APHM] (TIMONE)
Différenciation et communication neuronale et neuroendocrine (DC2N)
Université de Rouen Normandie (UNIROUEN)
Normandie Université (NU)-Normandie Université (NU)-Institut National de la Santé et de la Recherche Médicale (INSERM)
Normandie Université (NU)
Département d'endocrinologie
Hémodynamique, Interaction Fibrose et Invasivité tumorales Hépatiques (HIFIH)
Université d'Angers (UA)
Service de Chirurgie digestive, endocrinienne et générale [CHU Limoges]
CHU Limoges
Clinique de chirurgie digestive et endocrinienne
IMAD
Source :
British journal of surgery, British journal of surgery, 2013, 100 (10), pp.1312-1317. ⟨10.1002/bjs.9210⟩
Publication Year :
2013
Publisher :
HAL CCSD, 2013.

Abstract

Background The treatment of papillary thyroid carcinomas larger than 1 cm usually consists of total thyroidectomy and central lymph node dissection (LND). In patients with the follicular variant of papillary thyroid carcinoma (FVPTC), preoperative cytology and intraoperative frozen-section analysis cannot always establish the diagnosis. The aim of this study was to evaluate predictive factors for lymph node metastasis in patients with FVPTC and to identify patients who might benefit from LND. Methods The study included patients with FVPTC treated by total thyroidectomy and LND between 2000 and 2010 in four departments. When fewer than six non-involved lymph nodes were removed, the patient was excluded from the analysis. Results Some 199 patients were included. The median tumour size was 17 (range 1–85) mm, and tumours were classified as T1a in 28 patients, T1b in 40, T2 in 53, and T3 in 78. Eighty-one patients (40·7 per cent) had lymph node metastasis (51 classified as N1a and 30 as N1b). Four risk factors were predictive of lymph node metastasis in the multivariable analysis: multifocality (odds ratio (OR) 2·36, 95 per cent confidence interval 1·15 to 4·86), angiolymphatic invasion (OR 3·67, 1·01 to 13·36), absence of tumour capsule (OR 3·00, 1·47 to 6·14) and tumour involvement of perithyroid tissue (OR 3·89, 1·85 to 8·18). The rate of lymph node metastasis varied between 14 and 94 per cent depending on the presence of risk factors. Conclusion The rate of lymph node metastasis in patients with FVPTC varies widely according to the presence or absence of predictive risk factors.

Details

Language :
English
ISSN :
13652168
Database :
OpenAIRE
Journal :
British journal of surgery, British journal of surgery, 2013, 100 (10), pp.1312-1317. ⟨10.1002/bjs.9210⟩
Accession number :
edsair.doi.dedup.....3d9db5af592ec3403defa8afcd0ce635
Full Text :
https://doi.org/10.1002/bjs.9210⟩